Commission Implementing Decision of 27 June 2012 concerning a financial contribution by the Union to Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom for studies on Schmallenberg virus (notified under document C(2012) 4203) (Only the Dutch, English, French, German, Italian and Spanish texts are authentic) (2012/349/EU)

Article 1 U.K.

1. The Union shall grant Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom financial assistance for their scientific studies on Schmallenberg virus, as summarised in Annex I. The present decision constitutes a financing decision in the meaning of Article 75 of the Financial Regulation.

2. The financial contribution by the Union

(a) shall be at the rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the studies listed in Annex I and in accordance with the budgets listed in Annex II, for the period 1 April 2012 to 31 December 2013;

(b) shall not exceed the following:

(i)

EUR 438 615 for Belgium;

(ii)

EUR 595 883 for Germany;

(iii)

EUR 146 590 for Spain;

(iv)

EUR 589 380 for France;

(v)

EUR 124 120 for Italy;

(vi)

EUR 639 342 for the Netherlands;

(vii)

EUR 371 811 for the United Kingdom;

(c) Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom, or in cases when the scientific studies are carried out by more than one Member State in a consortium, the coordinator Member State as listed in Annex I, shall submit to the Commission:

• (c) no later than 31 March 2013 an intermediate technical report per project,

• no later than 31 March 2014 a final technical report per project;

(d) Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom shall submit to the Commission:

• (d) no later than 31 March 2014 a paper version and an electronic version of their financial report drawn up in accordance with Annex IV. The supporting documents, evidencing all the expenditure referred to in the application for reimbursement, shall be sent to the Commission on request;

(e) the outcome of the studies must be made available to the Commission, all Member States and EFSA and presented at the Standing Committee on the Food Chain and Animal Health.